ImmuCell shareholders reject say-on-pay and stock plan increase at 2025 annual meeting

IMMUCELL CORP /DE/

All seven director nominees elected; no director received more than 50% withhold.
Say-on-pay advisory resolution failed: 42.66% for, 50.71% against, remainder abstain.
Proposal to increase 2017 Plan shares from 650k to 900k failed: 41.10% for, 6.33% against.
Ratification of Wipfli LLP as auditor passed: 95.93% of votes cast in favor.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.